Form 4: Integral Ad Science CEO Lisa Utzschneider Reports Stock Sale to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Lisa Utzschneider, CEO of Integral Ad Science Holding Corp., sold 8,044 shares of common stock on May 6, 2024, to cover tax liabilities associated with the vesting and settlement of market stock units.

Summary

  • On May 6, 2024, Lisa Utzschneider, the CEO of Integral Ad Science Holding Corp., sold 8,044 shares of the company's common stock.
  • The sale was executed to cover tax obligations arising from the vesting and settlement of market stock units.
  • The shares were sold at a weighted average price of $9.97, with individual transactions ranging from $9.91 to $10.04 per share.
  • Following the transaction, Utzschneider directly owns 203,139 shares of Integral Ad Science Holding Corp.
  • The sale was conducted under a pre-arranged trading plan that satisfies the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a stock sale for tax purposes. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This sale appears to be related to tax obligations, which is a common reason for such transactions.

Stakeholder Impact

  • The stock sale by the CEO could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates

DateDescription
05/06/2024Date of stock sale transaction.
05/07/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.